Author

Syeda Mahrukh Naqvi

Institution: Moffitt Cancer Center

Observed institution: Moffitt Cancer Center

OpenAlex ID: A5124966293

Phase II trial of combination radiation, hormone, and immunotherapy in grade group 5 prostate cancer

2026 · John Michael Bryant, Maria Sandoval, et al. · Journal for ImmunoTherapy of Cancer · 1

Patient Redistribution Across Risk Categories in Differentiated Thyroid Cancer Using the 2025 Versus 2015 American Thyroid Association Risk Stratification Systems.

2026 · Lina Pedraza Sanchez, Larry Grullon-Polanco, et al. · Endocrine Practice

Outcomes of Elderly (≥ 70) Acute Myeloid Leukemia (AML) Patients Receiving Continued Hypomethylating Agent/Venetoclax (HMA/VEN) Versus Allogeneic Hematopoietic Cell Transplantation (HCT)

2026 · Onyee Chan, Reshma Ramlal, et al. · Transplantation and Cellular Therapy

Effect of GVHD Prophylaxis on Renal Function and Survival Outcomes in Allogeneic Hematopoietic Cell Transplant Patients with Pre-Existing Renal Impairment

2026 · Fnu Amisha, Jena Schmitz, et al. · Transplantation and Cellular Therapy

Works count: 4

Citation count: 1

H-index: 1

I10-index: